David Miller, PhD, has more than 25 years of experience in biomedical research as a scientist and a scientific policy and evaluation analyst. Before joining RLA Dr. Miller spent 16 years at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) at the National Institutes of Health (NIH), where he was involved in policy and evaluation activities that touched all aspects of the NIDDK portfolio and in the management of NIDDK’s HIV/AIDS-related research projects. He was also involved in cross-cutting projects that spanned the interests of multiple NIH Institutes, HHS agencies, patient and physician advocacy groups, and the U.S. Congress.
Dr. Miller received his BS in biology from Georgetown University and his PhD in biochemistry and molecular biology from the Lombardi Cancer Center at Georgetown University Medical School. His doctoral dissertation focused on the factors that regulate the growth of human breast cancer cells. During his postdoctoral studies at New York University Medical Center, his research interests encompassed the broader role of growth factors in cell proliferation, development, and disease.